Dysphagia is a relatively common complication of anterior cervical spine surgery. Smoking has not been definitively assessed as a risk factor for dysphagia. This study examined risk factors for dysphagia, including smoking and pain severity. The authors performed a cross-sectional cohort study of 100 patients who underwent anterior cervical diskectomy and fusion (ACDF). Dysphagia was assessed with the Yoo-Bazaz questionnaire. Clinical notes were reviewed for demographic information, diagnosis, preoperative pain severity, preoperative smoking status, and operative details. The dysphagia questionnaire was administered via telephone. The rate of dysphagia at an average of 2.75 years (33 months) was 26%. Rare and mild dysphagia were reported by 2% and 7% of patients, respectively. Moderate dysphagia was reported by 12% patients, and severe dysphagia was reported by 5% of patients. Smokers were more likely to report dysphagia symptoms, and their dysphagia scores were more severe than those in nonsmokers (1.17 vs 0.54; P=.02). Patients undergoing revision surgery (n=7) had dysphagia at a rate of 71% compared with 23% of patients undergoing primary surgery (P<.004). Age, sex, diagnosis, severity of preoperative pain, and number of levels treated did not reach statistical significance. The prevalence of persistent dysphagia at an average of 33 months after ACDF was 23% in primary cases. To the authors' knowledge, the severity of dysphagia in smokers has not been reported previously. These data confirm previous reports that dysphagia symptoms persist in a significant proportion of patients more than 1 year after anterior cervical spine surgery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3928/01477447-20150402-61 | DOI Listing |
Int J Lang Commun Disord
December 2024
Hearing, Speech & Language Center, Sheba Medical Center, Tel Hashomer, Israel.
Background: Head and neck cancer (HNC) is amongst the 10 most common cancers worldwide and has a major effect on patients' quality of life. Given the complexity of this unique group of patients, a multidisciplinary team approach is preferable. Amongst the debilitating sequels of HNC and/or its treatment, swallowing, speech and voice impairments are prevalent and require the involvement of speech-language pathologists (SLPs).
View Article and Find Full Text PDFIntern Emerg Med
December 2024
Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
Eosinophilic oesophagitis (EoE) is a chronic and progressive immune-mediated condition, typically affecting young atopic male adults and potentially leads to organ dysfunction and fibrosis. The clinical spectrum widely varies -from non-troublesome dysphagia to food impaction- and hence the rate of misdiagnosis and diagnostic delay are high, especially when presenting with minor symptoms, such as heartburn and acid regurgitation. There have been several major therapeutic breakthroughs for the management of EoE in recent years.
View Article and Find Full Text PDFDysphagia
December 2024
Department of Otorhinolaryngology-Head and Neck Surgery, Rennes University Hospital, 2 Rue Henri Le Guilloux, Rennes CEDEX 9, 35033, France.
Videofluoroscopy, recognized as the gold standard for dysphagia exploration, has inherent limitations, including poor soft tissue discrimination, radiation exposure, and aspiration risk. In response to these challenges, cine-MRI of swallowing has evolved over the past three decades, yielding diverse methodologies and results across various studies.This systematic review, conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, meticulously outlines cine-MRI protocols, applications, advantages, and limitations.
View Article and Find Full Text PDFToxins (Basel)
December 2024
Department of Neurology, Tokushima University, Tokushima 770-8503, Japan.
Oromandibular dystonia (OMD) is a focal dystonia characterized by contractions of the masticatory, lingual, and other muscles of the stomatognathic system. We conducted a systematic review and meta-analysis to elucidate the impact and safety of botulinum toxin in OMD. The eligibility criteria were full-length original articles that provided data evaluating the efficacy and adverse effects of onabotulinumtoxinA injections in patients with OMD.
View Article and Find Full Text PDFGeriatrics (Basel)
December 2024
Klinik für Herzchirurgie, Klinikum Nürnberg-Paracelsus Medical University, 90471 Nuremberg, Germany.
We report the case of a 78-year-old female patient who received palliative immunotherapy with pembrolizumab and lenvatinib as a treatment of pulmonary and osseous metastatic endometrial carcinoma. Under this therapy, the patient developed dysphagia, thyroiditis with hypothyroidism, myositis, and myocarditis, which required, due to third-degree AV block, the installation of a pacemaker. The patient received high-dose cortisone therapy, a thyroid hormone substitution, and pyridostigmine for symptom control.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!